Dallas, TX -- (SBWIRE) -- 03/13/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
Swift Energy Company (NYSE:SFY) moved up 2.03% and closed at $15.58. Recently, the Company announced that it has brought under control an outflow of water, oil and natural gas resulting from a marine vessel collision with a Swift Energy operated shut-in well head in the shallow waters of its Lake Washington field in Plaquemines Parish, Louisiana, which had occurred.
Get Latest News, Updates on SFY Here
Anworth Mortgage Asset Corporation (NYSE:ANH) augmented 2.0% and closed at $6.11. The 52-week range for the stock is $5.41 and $7.08. The Company has Price/Sales ratio of 7.55 and Price/Book ratio of 0.85. The 50-Day Moving Average and 200-Day Moving Average prices is $6.16 and $6.19 respectively. Anworth Mortgage Asset Corporation is a real estate investment trust. The Company is engaged in the business of investing primarily in United States, or the United States agency mortgage-backed securities.
Is ANH a Strong Buying Opportunity After The Recent Slump? Find out Here
Newmont Mining Corp (NYSE:NEM) went up 1.98% and closed at $39.66. The Company announced the completion of its previously announced acquisition of the Hope Bay Project located in Nunavut, Canada from Hope Bay Mining Ltd., subsidiary of Newmont Mining Corporation. In conjunction with the acquisition, TMAC has completed its previously announced private placement consisting of 1,276,259 flow-through common shares at a price of $3.40 per share and 10,220,240 common shares at a price of $3.00 per share for aggregate gross proceeds of $35 million.
Is NEM Signaling a Buy After The Sudden Gain? Don’t Miss Out Free Trend Analysis Here
Actavis Inc. (NYSE:ACT) went up 1.96% and closed at $90.10. The company confirmed that it has filed with the U.S. Food and Drug Administration an amendment to its Abbreviated New Drug Application for Rivastigmine Transdermal System to include the 13.3 mg per 24 hours dosage strength. Actavis' ANDA product is a generic version of Novartis' Exelon Patch, which is a prescription medicine used to treat people with mild to moderate dementia associated with Alzheimer's or Parkinson's disease.
Is ACT Signaling a Buy After The Sudden Gain? Don’t Miss Out Free Trend Analysis Here
Marketbuzzreport.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. Marketbuzzreport.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.marketbuzzreport.com
The assembled information disseminated by Marketbuzzreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Marketbuzzreport.com does expect that investors will buy and sell securities based on information assembled and presented in Marketbuzzreport.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)